Novel adamantane-nitrone hybrids: design, synthesis, and their multi-target neuroprotective effects against ischemic stroke
- 1Department of Neurosurgery, Affiliated Hospital of Nantong University
- 2Nantong Key Laboratory of Small Molecular Drug Innovation, School of Medicine, Nantong University
- 3Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, School of Pharmacy, Nantong University
Abstract
Introduction: Ischemic stroke involves interconnected pathological processes, including calcium overload, oxidative stress, apoptosis, and inflammation. This complexity challenges therapies directed at a single target, while limited blood–brain barrier (BBB) permeability can restrict drug delivery to the brain. This study aimed to develop hybrid compounds with favorable BBB permeability and multi-target neuroprotective activity.
Methods: Four adamantane–nitrone hybrids (TA1–TA4) were synthesized and screened for cytotoxicity and neuroprotective activity, leading to the selection of TA1. TA1 was then evaluated for its effects on calcium overload, oxidative stress, mitochondrial function, and BBB permeability in vitro, and for therapeutic efficacy and related signaling pathways in MCAO mice. Single-dose safety was assessed separately.
Results: TA1 showed the highest neuroprotective activity and lowest cytotoxicity among the four hybrids. It reduced calcium overload, scavenged ROS and ONOO ⁻ , and stabilized mitochondrial membrane potential. TA1 exhibited favorable BBB permeability (P app = 6.73 × 10 ⁻⁶ cm/s) and ameliorated ischemia-induced barrier disruption. In MCAO mice, intravenous TA1 reduced cerebral infarct volume from 32.97% to 14.33%, outperforming the positive control TBN. It also alleviated brain edema and improved neurobehavioral outcomes. TA1 modulated the Bax/Bcl-2/caspase-3, Nrf2/HO-1, and NF-κB pathways. No overt abnormalities were observed in the measured hematological, biochemical, or histopathological indices 48 h after a single intravenous dose of 136 μmol/kg.
Discussion: TA1 combines favorable BBB permeability with multi-target anti-apoptotic, antioxidant, and anti-inflammatory effects, supporting its further investigation as a candidate for ischemic stroke treatment.
Related
- Neuroprotective Mechanisms of Sinomenine in Ischemic Stroke: The Role of Fermt2 in Neuroinflammation.
- Benefit Expectations and Neuroprotective Prescribing for Acute Ischemic Stroke in China
- A multi-dimensional comparative evaluation of ten injectable neuroprotective agents for acute ischemic stroke based on the Chinese guideline for drug selection
- Design, synthesis, and biological activity studies of novel iron-chelating hybrids targeting pathological pathways associated with Alzheimer’s disease.
- Design, Synthesis, and Biological Evaluation of Molecular Hybrids Incorporating Coumarin-Pyrazole-Linked Indolinone Derivatives With Antioxidant and Anti-Alzheimer Properties.
BibTeX
@article{lu2026novel,
title = {{Novel adamantane-nitrone hybrids: design, synthesis, and their multi-target neuroprotective effects against ischemic stroke}},
author = {Hao Lu and Jiaxin Zheng and Ningning Luo and Chi Zhang and Xiao Liu and Xiaotong Wang and Yun Liu and Yong Ling and Xing Su},
journal = {Frontiers in Pharmacology},
year = {2026},
month = oct,
doi = {10.3389/fphar.2026.1974944},
url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1974944/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Novel adamantane-nitrone hybrids: design, synthesis, and their multi-target neuroprotective effects against ischemic stroke
AU - Hao Lu
AU - Jiaxin Zheng
AU - Ningning Luo
AU - Chi Zhang
AU - Xiao Liu
AU - Xiaotong Wang
AU - Yun Liu
AU - Yong Ling
AU - Xing Su
PY - 2026
DA - 2026/10/19
JO - Frontiers in Pharmacology
DO - 10.3389/fphar.2026.1974944
UR - https://www.frontiersin.org/articles/10.3389/fphar.2026.1974944/full
AB - Introduction: Ischemic stroke involves interconnected pathological processes, including calcium overload, oxidative stress, apoptosis, and inflammation. This complexity challenges therapies directed at a single target, while limited blood–brain barrier (BBB) permeability can restrict drug delivery to the brain. This study aimed to develop hybrid compounds with favorable BBB permeability and multi-target neuroprotective activity. Methods: Four adamantane–nitrone hybrids (TA1–TA4) were synthesized and screened for cytotoxicity and neuroprotective activity, leading to the selection of TA1. TA1 was then evaluated for its effects on calcium overload, oxidative stress, mitochondrial function, and BBB permeability in vitro, and for therapeutic efficacy and related signaling pathways in MCAO mice. Single-dose safety was assessed separately. Results: TA1 showed the highest neuroprotective activity and lowest cytotoxicity among the four hybrids. It reduced calcium overload, scavenged ROS and ONOO ⁻ , and stabilized mitochondrial membrane potential. TA1 exhibited favorable BBB permeability (P app = 6.73 × 10 ⁻⁶ cm/s) and ameliorated ischemia-induced barrier disruption. In MCAO mice, intravenous TA1 reduced cerebral infarct volume from 32.97% to 14.33%, outperforming the positive control TBN. It also alleviated brain edema and improved neurobehavioral outcomes. TA1 modulated the Bax/Bcl-2/caspase-3, Nrf2/HO-1, and NF-κB pathways. No overt abnormalities were observed in the measured hematological, biochemical, or histopathological indices 48 h after a single intravenous dose of 136 μmol/kg. Discussion: TA1 combines favorable BBB permeability with multi-target anti-apoptotic, antioxidant, and anti-inflammatory effects, supporting its further investigation as a candidate for ischemic stroke treatment.
SN - 1663-9812
ER -